Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Chapple

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
BJU International|June 18, 2010
A conversation between Chris Chapple and Darracott Vaughan. Interview by Darracott VaughanChris Chapple
Neurourology and Urodynamics|August 12, 2014
EditorialChris Chapple
Current Opinion in Urology|June 15, 2007
Specialist training in female urology and reconstructive urology: the UK experienceMalcolm Lucas, Simon Harrison, Chris Chapple
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 26, 2012
A new approach to patients with lower urinary tract symptoms (LUTS)Jonathan Rees, Julian Spinks, Chris Chapple
World Journal of Urology|November 17, 2009
Urgency as the cardinal symptom of overactive bladder: a critical analysisLinda Cardozo, Chris Chapple, Alan Wein
Urology|December 15, 2004
State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaBob Djavan, Chris Chapple, Shirin Milani, et al.
European Urology|August 11, 2016
Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016Christian Türk, Thomas Knoll, Christian Seitz, et al.
BJU International|March 5, 2011
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTSKarin S Coyne, Chris C Sexton, Zoe S Kopp, et al.
European Urology|April 28, 2018
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysisCon Kelleher, Zalmai Hakimi, Richard Zur, et al.
European Urology|July 26, 2011
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Altaf Mangera, Karl-Erik Andersson, Apostolos Apostolidis, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
BJU International|June 18, 2010
A conversation between Chris Chapple and Darracott Vaughan. Interview by Darracott VaughanChris Chapple
Neurourology and Urodynamics|August 12, 2014
EditorialChris Chapple
Current Opinion in Urology|June 15, 2007
Specialist training in female urology and reconstructive urology: the UK experienceMalcolm Lucas, Simon Harrison, Chris Chapple
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 26, 2012
A new approach to patients with lower urinary tract symptoms (LUTS)Jonathan Rees, Julian Spinks, Chris Chapple
World Journal of Urology|November 17, 2009
Urgency as the cardinal symptom of overactive bladder: a critical analysisLinda Cardozo, Chris Chapple, Alan Wein
Urology|December 15, 2004
State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaBob Djavan, Chris Chapple, Shirin Milani, et al.
European Urology|August 11, 2016
Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016Christian Türk, Thomas Knoll, Christian Seitz, et al.
BJU International|March 5, 2011
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTSKarin S Coyne, Chris C Sexton, Zoe S Kopp, et al.
European Urology|April 28, 2018
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysisCon Kelleher, Zalmai Hakimi, Richard Zur, et al.
European Urology|July 26, 2011
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Altaf Mangera, Karl-Erik Andersson, Apostolos Apostolidis, et al.
Pageof 3